Takehiko Katsurada
Sapporo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 39 publications
Infliximab-Responsive Severe Ulcerative Colitis With Pyoderma Gangrenosum After IL-6 and IGF-1 Blockade.
Journal: ACG case reports journal
Published: April 03, 2026
Long-term drug persistence and clinical outcomes of ustekinumab in Crohn's disease: a multicenter real-world study from the Hokkaido phoenix cohort.
Journal: Crohn's & colitis 360
Published: March 20, 2026
Short- and Long-Term Effectiveness and Safety of Vedolizumab in Crohn's Disease: A Multicenter Retrospective Study from the Hokkaido Phoenix Cohort.
Journal: Inflammatory intestinal diseases
Published: February 18, 2026
Severe upper gastrointestinal involvement in ulcerative colitis successfully treated with sequential therapy using intravenous tacrolimus and upadacitinib: a case report.
Journal: Frontiers in medicine
Published: February 17, 2026
Long-Term Outcomes and Prognostic Factors for Vedolizumab-Treated Japanese Patients with Ulcerative Colitis.
Journal: Inflammatory intestinal diseases
Published: July 26, 2025
Novel desensitization therapy of mesalamine intolerance in patients with ulcerative colitis.
Journal: Gastroenterologia y hepatologia
Published: November 15, 2024
Decreased Fecal Nicotinamide and Increased Bacterial Nicotinamidase Gene Expression in Ulcerative Colitis Patients.
Journal: Inflammatory bowel diseases
Published: November 12, 2024
Effectiveness of transabdominal ultrasonography in predicting clinical relapse of Crohn's disease.
Journal: Intestinal research
Published: August 06, 2023
Effectiveness and Factors Associated with Response to Golimumab in Japanese Patients with Ulcerative Colitis in Real Clinical Practice: The Phoenix Study.
Journal: Inflammatory intestinal diseases
Published: March 27, 2023
Last Updated: 09/26/2026